摘要
目的:探讨肝门部胆管癌病人根治术后经三腔胃肠管行早期肠内营养(EEN)的应用价值。方法:选取32例行肝门部胆管癌根治术的病人,分为三腔胃肠管组和普通胃管组(胃管+鼻肠营养管)。术后进行同样的EN治疗。观察两组病人肛门恢复排气时间、恶心、呕吐、腹泻、肺部感染、腹腔感染、切口感染、胃液引流量等。术后第8天,检测肝、肾功能等指标。结果:普通胃管组病人的肺部感染发生率明显高于三腔胃肠管组(P<0.05);三腔胃肠管组病人恶心、呕吐的发生率明显低于普通胃管组(P<0.05),两组间胃液引流量、肛门恢复排气时间、术后腹腔感染、切口感染等并发症的发生率均无显著性差异(P>0.05)。结论:肝门部胆管癌病人根治术后采用三腔胃肠管行EEN不仅安全可靠,耐受性好,而且能减少并发症的发生率。
Objective: To evaluate the value of early enteral nutrition (EEN) through Freka Trelumina (FT) , a new three-lumen gastrojejunal tube, in patients after operation of hilar cholangiocarcinoma. Methods: Thirty-two patients undergoing operation of hilar cholangiocarcinoma were divided into two groups: one-lumen tube group (nasojejunal + nasogastric tube, n = 15 ) and FT group (n = 17). The time required to restore anal exhaust, nausea/ vomiting, diarrhea, lung infection, abdominal infection, incision infection and liver-kidney function were observed. Results: In one-lumen tube group, the incidence of lung infection was more than in FT group ( P 〈 0.05 ). Nausea/vomiting hap- pened less in FT group than in one-lumen tube group. Other complications such as abdominal infection and incision infection were the same in the two groups (P 〉 0. 05 ). Conclusion: EEN through FT is feasible and safe in patients after operation of hilar eholangiocareinoma.
出处
《肠外与肠内营养》
CAS
北大核心
2013年第1期12-14,共3页
Parenteral & Enteral Nutrition
基金
国家十一五科技支撑计划课题(2006BA105A06)
关键词
三腔胃肠管
肠内营养
肝门部胆管癌
Freka Trelumina
Enteral nutrition
Hilar cholangiocarcinoma